A recent move by the Indian government to exempt customs duty on drugs and food items prescribed for special medical purposes and imported for personal use to treat rare diseases listed in the National Policy For Rare Diseases, 2021 is a win for groups that have been working to sensitize policy makers and regulators to the needs of rare disease patients.
Along with these drugs, Keytruda (pembrolizumab) from MSD, as Merck & Co., Inc. is known outside US and...







